Kidney Function After Islet Transplant Alone in Type 1 Diabetes
Open Access
- 1 May 2007
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (5) , 1150-1155
Abstract
OBJECTIVE—Islet transplantation alone is an alternative for the replacement of pancreatic endocrine function in patients with type 1 diabetes. The aim of our study was to assess the impact of the Edmonton immunosuppressive protocol (tacrolimus-sirolimus association) on kidney function.Keywords
This publication has 25 references indexed in Scilit:
- Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimenTransplant International, 2005
- Proteinuria Developing After Clinical Islet Transplantation Resolves with Sirolimus Withdrawal and Increased Tacrolimus DosingAmerican Journal of Transplantation, 2005
- Sirolimus in Combination with Tacrolimus Is Associated with Worse Renal Allograft Survival Compared to Mycophenolate Mofetil Combined with TacrolimusAmerican Journal of Transplantation, 2005
- Diabetic NephropathyDiabetes Care, 2005
- Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathiesNephrology Dialysis Transplantation, 2004
- Islet Transplantation Is Associated with Improvement of Renal Function among Uremic Patients with Type I Diabetes Mellitus and Kidney TransplantsJournal of the American Society of Nephrology, 2003
- Severe acute renal failure after exposure to sirolimus-tacrolimus in two livin donor kidney reciplentsTransplantation, 2003
- Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipientsKidney International, 1995
- Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinasesCell, 1992
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976